OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Observational
Change patient management
403 Publications
found
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.
b
Cancer research and treatment
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Impact of Direct From Blood Culture Identification of Pathogens Paired With Antimicrobial Stewardship Interventions in a Pediatric Hospital.
b
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
January 1, 2021
p
MALDI-TOF MS For Microorganism Identification
c
Change patient management
Observational
Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.
b
PloS one
January 1, 2021
p
Diabetes
c
Change patient management
Clinical outcomes
Observational
Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
b
PloS one
January 1, 2021
p
Diabetes
c
Change patient management
Observational
Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series.
b
The Israel Medical Association journal : IMAJ
December 1, 2020
p
Cancer
c
Change patient management
Observational
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
b
Investigational new drugs
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.
b
Clinical cancer research : an official journal of the American Association for Cancer Research
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
b
The oncologist
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
b
JAMA oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
b
The Lancet. Oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Previous Page
1
…
16
17
18
19
20
…
41
Next Page
